| Role |
Name |
Disclosure |
Details |
| Author | Teresa L Massagli, MD, Residency Director, Professor, Department of Rehabilitation Medicine and Pediatrics, University of Washington School of Medicine | Nothing to disclose | Details | | Coauthor | Maria Regina L Reyes, MD, Acting Assistant Professor, Department of Rehabilitation Medicine, University of Washington; Medical Director, Inpatient Rehabilitation Medicine Service and Rehabilitation Consultation Service, University of Washington Medical Center | Nothing to disclose | Details | | Medical Editor | Patrick J Potter, BSc, MD, FRCP(C), Associate Professor, Physical Medicine and Rehabilitation, The University of Western Ontario; Consulting Staff, Department of Physical Medicine and Rehabilitation, St Joseph's Health Care Centre | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Kat Kolaski, MD, Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine | Nothing to disclose | Details | | CME Editor | Kelly L Allen, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Lourdes Regional Rehabilitation Center, Our Lady of Lourdes Medical Center | Nothing to disclose | Details | | Chief Editor | Denise I Campagnolo, MD, MS, Director of Multiple Sclerosis Clinical Research and Staff Physiatrist, Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center; Investigator for Barrow Neurology Clinics; Director, NARCOMS Project for Consortium of MS Centers, Phoenix | Teva Neuroscience Serono-Pfizer | Details |
|